跳至主要内容
临床试验/NCT01209429
NCT01209429已完成不适用

Importance of the GH/IGF-1 Axis for Human Substrate and Energy Metabolism During Calorie Restriction

University of Aarhus1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2010年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
10
试验地点
1
主要终点
Description of intracellular pathways to clarify the interplay between calorie restriction, SIRT1, STATb5, and the GH/IGF-I axis

研究概览

简要总结

This study will investigate whether growth hormone is modulated by the enzyme SIRT1 and by that is stimulating lipolysis on expense of IGF-I production. This is done in 10 healthy men on calorie restriction on 4 study days with fat and skeletal muscle biopsies.

详细描述

It has been shown that calorie restriction enhances the length of life in yeast, worms, fish and rodent. Whether this elongation of life due to calorie restriction can be applied to humans is not known. However, it is a fact that calorie restriction will decrease the risk of developing metabolic disturbances such as diabetes, hypertension and atherosclerosis.

On the molecular level the specific relations are not fully understood. This study will investigate the possible connection between SITR1 and the relation to the GH/IGF-I axis and STAT5b in healthy men. The participant will fast 42 and 12 hours respectively, and have GH or placebo infusions. The design is a classical 2x2 design and will be randomized.

Knowledge of the interactions between calorie restriction, SIRT1, STAT5b and the GH/IGF-I axis will apply important information about the relations between aging, energy metabolism and metabolic disturbances.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Factorial
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • healthy lean men

排除标准

  • metabolic disturbances
  • alcohol drug abuse
  • malign disease: current or previous

研究组 & 干预措施

42 hour fast/GH infusion

Experimental

干预措施: GH hormone infusion (Drug)

42 hour fast/GH infusion

Experimental

干预措施: 42 hour fast (Behavioral)

42 hour fast/Placebo infusion

Experimental

干预措施: 42 hour fast (Behavioral)

12 hour fast/GH infusion

Experimental

干预措施: GH hormone infusion (Drug)

12 hour fast/GH infusion

Experimental

干预措施: 12 hour fast (Behavioral)

12 hour fast/Placebo infusion

Placebo Comparator

干预措施: 12 hour fast (Behavioral)

结局指标

主要结局

Description of intracellular pathways to clarify the interplay between calorie restriction, SIRT1, STATb5, and the GH/IGF-I axis

时间窗: 6 hour study days

All study days consists of 3 hour basic periods and 3 hours hyperinsulinemic, euglycemic clamp.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Birgitte Nellemann

MD PhD student

University of Aarhus

研究点 (1)

Loading locations...

相似试验